Name: UMIN ID:
Unique ID issued by UMIN | UMIN000041263 |
---|---|
Receipt number | R000047121 |
Scientific Title | Prospective multicenter observational study of atezolizumab combination therapy in patients with unresectable, advanced and recurrent non-small cell lung cancer or extensive disease small cell lung cancer |
Date of disclosure of the study information | 2020/08/01 |
Last modified on | 2023/01/31 09:11:36 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2020/07/30 19:54:46 | ||
2 | Update | 2020/10/16 16:25:53 | Recruitment status |
|
3 | Update | 2022/03/22 08:29:43 | Recruitment status |
|
4 | Update | 2022/07/25 10:09:51 | Key secondary outcomes Key secondary outcomes |
|
5 | Update | 2022/07/25 10:14:14 | Organization Division name Division name Organization Organization Division name Division name Organization Organization Division name Division name |
|
6 | Update | 2022/07/25 10:16:03 | Last follow-up date Date of closure to data entry Date trial data considered complete |
|
7 | Update | 2023/01/31 09:11:36 | Date trial data considered complete Date analysis concluded |